169 related articles for article (PubMed ID: 3285914)
21. Induction chemotherapy for newly diagnosed acute myeloid leukaemia using a regime containing cytosine arabinoside, daunorubicin and etoposide.
Liang R; Chiu E; Chan TK; Todd D
Cancer Chemother Pharmacol; 1990; 26(5):380-2. PubMed ID: 2208581
[TBL] [Abstract][Full Text] [Related]
22. [Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide].
Robak T; Krykowski E; Matusewicz W; Brodowski L; Hołub A; Drzewoski J
Pol Tyg Lek; 1988 Nov; 43(47):1508-11. PubMed ID: 3075284
[No Abstract] [Full Text] [Related]
23. Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.
Krug U; Röllig C; Koschmieder A; Heinecke A; Sauerland MC; Schaich M; Thiede C; Kramer M; Braess J; Spiekermann K; Haferlach T; Haferlach C; Koschmieder S; Rohde C; Serve H; Wörmann B; Hiddemann W; Ehninger G; Berdel WE; Büchner T; Müller-Tidow C; ;
Lancet; 2010 Dec; 376(9757):2000-8. PubMed ID: 21131036
[TBL] [Abstract][Full Text] [Related]
24. Preliminary results of intensive therapy of children and adolescents with acute nonlymphocytic leukemia--a Childrens Cancer Study Group report.
Lampkin BC; Woods WG; Buckley JD; Hammond GD
Haematol Blood Transfus; 1990; 33():210-4. PubMed ID: 1691130
[No Abstract] [Full Text] [Related]
25. Intensive sequential post-induction therapy for adults with acute myelogenous leukemia in first remission: long-term follow-up and results.
Ino T; Kojima H; Miyazaki H; Maruyama F; Sobue R; Okamoto M; Matsui T; Shimizu K; Ezaki K; Hirano M
Leuk Res; 1992; 16(6-7):577-84. PubMed ID: 1635375
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy of adult acute myeloid leukaemia.
Suri R; Kueh YK; Han P; Tan YO
Ann Acad Med Singap; 1990 Mar; 19(2):175-7. PubMed ID: 2346291
[TBL] [Abstract][Full Text] [Related]
27. Intensive sequential chemotherapy for children with acute myelogenous leukemia.
Grier HE; Gelber RD; Clavell LA; Camitta BM; Link MP; Garcea MJ; Weinstein HJ
Haematol Blood Transfus; 1990; 33():193-7. PubMed ID: 2182411
[No Abstract] [Full Text] [Related]
28. [Short-term intensive consolidation chemotherapy in the treatment of acute non-lymphocytic leukemia].
Nagata K; Hatanaka T; Ito T; Saito M; Ono Y; Kamiya O; Ohara K
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1079-81. PubMed ID: 1626944
[No Abstract] [Full Text] [Related]
29. Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
Bradstock KF; Link E; Di Iulio J; Szer J; Marlton P; Wei AH; Enno A; Schwarer A; Lewis ID; D'Rozario J; Coyle L; Cull G; Campbell P; Leahy MF; Hahn U; Cannell P; Tiley C; Lowenthal RM; Moore J; Cartwright K; Cunningham I; Taper J; Grigg A; Roberts AW; Benson W; Hertzberg M; Deveridge S; Rowlings P; Mills AK; Gill D; Bardy P; Campbell L; Seymour JF;
J Clin Oncol; 2017 May; 35(15):1678-1685. PubMed ID: 28368672
[TBL] [Abstract][Full Text] [Related]
30. Remission induction with cytarabine and daunorubicin with or without 6-thioguanine in adult patients with acute myelocytic leukemia.
Nowrousian MR; Pfeiffer R; Schaefer UW; Osieka R; Niederle N; Anders C; Schmidt CG
Haematol Blood Transfus; 1987; 30():352-5. PubMed ID: 3305206
[No Abstract] [Full Text] [Related]
31. Intensive induction and consolidation chemotherapy in a young woman with acute myeloid leukemia and severe chronic renal failure.
Hardegger TP; von Rohr A; Tobler A; Fey MF
Ann Hematol; 1996 May; 72(5):327-8. PubMed ID: 8645746
[No Abstract] [Full Text] [Related]
32. Acute nonlymphocytic leukemia in adults: results obtained with TAD remission induction therapy.
Witteveen EO; Verdonck LF; Nieuwenhuis HK; Dekker AW
Haematol Blood Transfus; 1990; 33():309-13. PubMed ID: 2323635
[No Abstract] [Full Text] [Related]
33. A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.
Wiernik PH; Case DC; Periman PO; Arlin ZA; Weitberg AB; Ritch PS; Todd MB
Semin Oncol; 1989 Feb; 16(1 Suppl 2):25-9. PubMed ID: 2928807
[No Abstract] [Full Text] [Related]
34. Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse.
Pilorge S; Rigaudeau S; Rabian F; Sarkozy C; Taksin AL; Farhat H; Merabet F; Ghez S; Raggueneau V; Terré C; Garcia I; Renneville A; Preudhomme C; Castaigne S; Rousselot P
Am J Hematol; 2014 Apr; 89(4):399-403. PubMed ID: 24375467
[TBL] [Abstract][Full Text] [Related]
35. Idarubicin in combination with etoposide and cytarabine in adult acute non-lymphoblastic leukaemia (ANLL).
Carella AM; Pungolino E; Piatti G; Giordano D; Cerri R; Risso M; Nati S
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():50-1. PubMed ID: 2713562
[No Abstract] [Full Text] [Related]
36. Comparison of neutropenia profiles in different treatment protocols for acute myeloid leukemia using the D-index.
Kawasaki Y; Kimura SI; Nakano H; Mashima K; Shirato Y; Kawaguchi SI; Toda Y; Ochi SI; Nagayama T; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Sato K; Oh I; Fujiwara SI; Ohmine K; Kako S; Muroi K; Kanda Y
Int J Hematol; 2019 Apr; 109(4):470-476. PubMed ID: 30684252
[TBL] [Abstract][Full Text] [Related]
37. [Acute myelogenous leukemia in elderly patients].
Mori M
Nihon Ronen Igakkai Zasshi; 2000 Mar; 37(3):192-6. PubMed ID: 10879065
[No Abstract] [Full Text] [Related]
38. [Effect of etoposide added to individualized induction therapy of adult acute myeloid leukemia--the JALSG-AML-92 Study. Japan Adult Leukemia Study Group].
Miyawaki S; Tanimoto M; Kobayashi T; Minami S; Tamura J; Omoto E; Kuriyama K; Hatake K; Saito K; Ohno R
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1160-7. PubMed ID: 10945011
[TBL] [Abstract][Full Text] [Related]
39. Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.
Champlin R; Gajewski J; Nimer S; Vollset S; Landaw E; Winston D; Schiller G; Ho W
J Clin Oncol; 1990 Jul; 8(7):1199-206. PubMed ID: 1694236
[TBL] [Abstract][Full Text] [Related]
40. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
